106 related articles for article (PubMed ID: 8584583)
1. Comparison of coronary microvascular response to nipradilol and nitroglycerin.
Lamping KG; Bloom EN
Pharmacology; 1995 Nov; 51(5):315-22. PubMed ID: 8584583
[TBL] [Abstract][Full Text] [Related]
2. Effects of nitroglycerin on the coronary microcirculation in normal and ischemic myocardium.
Kanatsuka H; Eastham CL; Marcus ML; Lamping KG
J Cardiovasc Pharmacol; 1992 May; 19(5):755-63. PubMed ID: 1381774
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro vasoactive reactions of coronary arteriolar microvessels to nitroglycerin.
Jones CJ; Kuo L; Davis MJ; Chilian WM
Am J Physiol; 1996 Aug; 271(2 Pt 2):H461-8. PubMed ID: 8770085
[TBL] [Abstract][Full Text] [Related]
4. Effects of nipradilol on the microvascular tone of rat mesentery: comparison with other beta-blockers and vasodilators.
Araki H; Itoh M; Nishi K
Arch Int Pharmacodyn Ther; 1992; 318():47-54. PubMed ID: 1361123
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin.
Kurz MA; Lamping KG; Bates JN; Eastham CL; Marcus ML; Harrison DG
Circ Res; 1991 Mar; 68(3):847-55. PubMed ID: 1742870
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of nipradilol, a beta-adrenoceptor blocker with vasodilating properties.
Fujii M; Shirasawa Y; Kondo S; Sawanobori K; Nakamura M
Jpn Heart J; 1986 Mar; 27(2):233-50. PubMed ID: 2873263
[TBL] [Abstract][Full Text] [Related]
7. Coronary microvascular response to endothelin is dependent on vessel diameter and route of administration.
Lamping KG; Clothier JL; Eastham CL; Marcus ML
Am J Physiol; 1992 Sep; 263(3 Pt 2):H703-9. PubMed ID: 1415594
[TBL] [Abstract][Full Text] [Related]
8. Effects of an antihypertensive agent, nipradilol, on isolated coronary artery of the dog.
Sakanashi M; Takeo S; Ito H; Noguchi K; Miyamato Y; Higa T
Pharmacology; 1984; 29(5):241-6. PubMed ID: 6149568
[TBL] [Abstract][Full Text] [Related]
9. Coronary microvascular responses to reductions in perfusion pressure. Evidence for persistent arteriolar vasomotor tone during coronary hypoperfusion.
Chilian WM; Layne SM
Circ Res; 1990 May; 66(5):1227-38. PubMed ID: 2335023
[TBL] [Abstract][Full Text] [Related]
10. Nipradilol depresses cardiac contractility and O2 consumption without decreasing coronary resistance in dogs.
Zhao DD; Namba T; Araki J; Ishioka K; Takaki M; Suga H
Acta Med Okayama; 1993 Feb; 47(1):29-33. PubMed ID: 8096354
[TBL] [Abstract][Full Text] [Related]
11. [Effects of nitroglycerin and of the combination of nitroglycerin and beta inhibitors on systemic and coronary hemodynamics and on cardiac metabolism].
Marchetti GV; Merlo L; Brusoni B
Boll Soc Ital Cardiol; 1975; 20(10):1197-205. PubMed ID: 10931
[No Abstract] [Full Text] [Related]
12. Effects of topical nipradilol, a beta-blocking agent with alpha-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulation.
Kanno M; Araie M; Tomita K; Sawanobori K
Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):736-43. PubMed ID: 9538880
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous microvascular coronary vasodilation by adenosine and nitroglycerin in dogs.
Habazettl H; Vollmar B; Christ M; Baier H; Conzen PF; Peter K
J Appl Physiol (1985); 1994 May; 76(5):1951-60. PubMed ID: 8063655
[TBL] [Abstract][Full Text] [Related]
14. Effects of alpha and beta adrenergic blockade on coronary arterial microvessels in the beating canine heart.
Sekiguchi N; Kanatsuka H; Komaru T; Akai K; Sato K; Wang Y; Sugi M; Ashikawa K; Takishima T
Cardiovasc Res; 1992 Apr; 26(4):415-21. PubMed ID: 1353415
[TBL] [Abstract][Full Text] [Related]
15. Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand.
Jones CJ; Kuo L; Davis MJ; DeFily DV; Chilian WM
Circulation; 1995 Mar; 91(6):1807-13. PubMed ID: 7882491
[TBL] [Abstract][Full Text] [Related]
16. Canine retinal arterial and arteriolar dilatation induced by nipradilol, a possible glaucoma therapeutic.
Okamura T; Kitamura Y; Uchiyama M; Toda M; Ayajiki K; Toda N
Pharmacology; 1996 Nov; 53(5):302-10. PubMed ID: 8990489
[TBL] [Abstract][Full Text] [Related]
17. Impaired dilation of coronary arterioles during increases in myocardial O(2) consumption with hyperglycemia.
Ammar RF; Gutterman DD; Brooks LA; Dellsperger KC
Am J Physiol Endocrinol Metab; 2000 Oct; 279(4):E868-74. PubMed ID: 11001770
[TBL] [Abstract][Full Text] [Related]
18. Relative importance of calcium-activated potassium channels in nipradilol-induced aortic relaxation in rats.
Uchida T; Toki Y; Fukami Y; Kamiya H; Matsui H; Okumura K; Ito T; Hayakawa T
Arzneimittelforschung; 2001; 51(5):383-6. PubMed ID: 11413738
[TBL] [Abstract][Full Text] [Related]
19. Contribution of cyclic GMP generation to the relaxation by nipradilol in the rabbit aorta.
Sasage H; Nakazawa M; Arakawa M; Imai S
Gen Pharmacol; 1995 Jan; 26(1):85-91. PubMed ID: 7713370
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous microvascular coronary alpha-adrenergic vasoconstriction.
Chilian WM; Layne SM; Eastham CL; Marcus ML
Circ Res; 1989 Feb; 64(2):376-88. PubMed ID: 2563238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
